Doctors are urging Americans aged 6 months and older to get vaccinated against the flu after an unusual early rise in cases ...
On October 19, 2026, Shah Capital Fund LLC disclosed the sale of 2.87 million shares worth approximately $32.6 million, withdrew its registration as an investment adviser with the SEC, and ...
Wall Street is quite bullish on BioNTech. In fact, among the 20 analysts covering it, 13 rate the stock a strong buy, while ...
The FDA-approved, new mRNA flu shot is now available for adults 50 and older. HealthLink explores how it stacks up against ...
This particular company, a biotech innovator, has seen its shares surge more than 600% this year, largely outperforming ...
A Danish university has approved a CDC-funded study in African newborns, in which only half of babies will receive the ...
BioNTech's BNT113 missed progression-free survival in an HPV-linked head and neck cancer trial; study continues to test ...
Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine ...
Flu season has started early this year. The number of cases has been rising is the past few weeks at a faster clip than in ...
IntroductionRegarding vaccines, there is data showing that vaccinated individuals had fewer illnesses and that patient ...
(The Conversation) – The number of people sick with flu is starting to increase across the United States, with health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results